TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.43 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +43.17% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2017 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 76.0K | 116.0K | 135.0K | -- | ||
| Operating Expenses | Gross Income | -76.0K | -116.0K | -135.0K | 0.00 | |
| General Expenses | 4.0M | 8.3M | 10.6M | 12.1M | ||
| Research And Development | 2.7M | 6.1M | 7.8M | 8.8M | ||
| Total Operating Expenses | 4.0M | 8.4M | 10.8M | 12.1M | ||
| Non-Operating Expenses | Operating Income | -4.0M | -8.4M | -10.8M | -12.1M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.0M | -7.7M | -9.9M | -11.1M | |
| Preferred Dividend | -522.0K | -3.7M | -49.9M | 0.00 | ||
| Net Income | -4.0M | -7.7M | -9.9M | -11.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.9M | 23.9M | 12.3M | 23.8M | |
| Shares To Calculate EPS Diluted | 23.9M | 23.9M | 12.3M | 23.8M | ||
| Earnings Per Share | EPS | -$0.19 | -$0.48 | -$4.85 | -$0.46 | |
| EPS Diluted | -$0.19 | -$0.48 | -$4.85 | -$0.46 | ||
